Myriad Genetics Inc
NASDAQ:MYGN

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
NASDAQ:MYGN
Watchlist
Price: 16.17 USD 2.93% Market Closed
Market Cap: 1.5B USD
Have any thoughts about
Myriad Genetics Inc?
Write Note

Intrinsic Value

The intrinsic value of one MYGN stock under the Base Case scenario is 22.15 USD. Compared to the current market price of 16.17 USD, Myriad Genetics Inc is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MYGN Intrinsic Value
22.15 USD
Undervaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Myriad Genetics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MYGN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MYGN?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Myriad Genetics Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Myriad Genetics Inc

Provide an overview of the primary business activities
of Myriad Genetics Inc.

What unique competitive advantages
does Myriad Genetics Inc hold over its rivals?

What risks and challenges
does Myriad Genetics Inc face in the near future?

Has there been any significant insider trading activity
in Myriad Genetics Inc recently?

Summarize the latest earnings call
of Myriad Genetics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Myriad Genetics Inc.

Provide P/S
for Myriad Genetics Inc.

Provide P/E
for Myriad Genetics Inc.

Provide P/OCF
for Myriad Genetics Inc.

Provide P/FCFE
for Myriad Genetics Inc.

Provide P/B
for Myriad Genetics Inc.

Provide EV/S
for Myriad Genetics Inc.

Provide EV/GP
for Myriad Genetics Inc.

Provide EV/EBITDA
for Myriad Genetics Inc.

Provide EV/EBIT
for Myriad Genetics Inc.

Provide EV/OCF
for Myriad Genetics Inc.

Provide EV/FCFF
for Myriad Genetics Inc.

Provide EV/IC
for Myriad Genetics Inc.

Show me price targets
for Myriad Genetics Inc made by professional analysts.

What are the Revenue projections
for Myriad Genetics Inc?

How accurate were the past Revenue estimates
for Myriad Genetics Inc?

What are the Net Income projections
for Myriad Genetics Inc?

How accurate were the past Net Income estimates
for Myriad Genetics Inc?

What are the EPS projections
for Myriad Genetics Inc?

How accurate were the past EPS estimates
for Myriad Genetics Inc?

What are the EBIT projections
for Myriad Genetics Inc?

How accurate were the past EBIT estimates
for Myriad Genetics Inc?

Compare the revenue forecasts
for Myriad Genetics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Myriad Genetics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Myriad Genetics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Myriad Genetics Inc compared to its peers.

Compare the P/E ratios
of Myriad Genetics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Myriad Genetics Inc with its peers.

Analyze the financial leverage
of Myriad Genetics Inc compared to its main competitors.

Show all profitability ratios
for Myriad Genetics Inc.

Provide ROE
for Myriad Genetics Inc.

Provide ROA
for Myriad Genetics Inc.

Provide ROIC
for Myriad Genetics Inc.

Provide ROCE
for Myriad Genetics Inc.

Provide Gross Margin
for Myriad Genetics Inc.

Provide Operating Margin
for Myriad Genetics Inc.

Provide Net Margin
for Myriad Genetics Inc.

Provide FCF Margin
for Myriad Genetics Inc.

Show all solvency ratios
for Myriad Genetics Inc.

Provide D/E Ratio
for Myriad Genetics Inc.

Provide D/A Ratio
for Myriad Genetics Inc.

Provide Interest Coverage Ratio
for Myriad Genetics Inc.

Provide Altman Z-Score Ratio
for Myriad Genetics Inc.

Provide Quick Ratio
for Myriad Genetics Inc.

Provide Current Ratio
for Myriad Genetics Inc.

Provide Cash Ratio
for Myriad Genetics Inc.

What is the historical Revenue growth
over the last 5 years for Myriad Genetics Inc?

What is the historical Net Income growth
over the last 5 years for Myriad Genetics Inc?

What is the current Free Cash Flow
of Myriad Genetics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Myriad Genetics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Myriad Genetics Inc

Current Assets 291.6m
Cash & Short-Term Investments 97.3m
Receivables 117.8m
Other Current Assets 76.5m
Non-Current Assets 793.5m
PP&E 172.8m
Intangibles 605.8m
Other Non-Current Assets 14.9m
Current Liabilities 148.9m
Accounts Payable 33.3m
Accrued Liabilities 92.6m
Other Current Liabilities 23m
Non-Current Liabilities 195.7m
Long-Term Debt 38.8m
Other Non-Current Liabilities 156.9m
Efficiency

Earnings Waterfall
Myriad Genetics Inc

Revenue
823.6m USD
Cost of Revenue
-254.1m USD
Gross Profit
569.5m USD
Operating Expenses
-664m USD
Operating Income
-94.5m USD
Other Expenses
-21.5m USD
Net Income
-116m USD

Free Cash Flow Analysis
Myriad Genetics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MYGN Profitability Score
Profitability Due Diligence

Myriad Genetics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
ROIC is Increasing
Positive 3-Years Revenue Growth
29/100
Profitability
Score

Myriad Genetics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

MYGN Solvency Score
Solvency Due Diligence

Myriad Genetics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
61/100
Solvency
Score

Myriad Genetics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MYGN Price Targets Summary
Myriad Genetics Inc

Wall Street analysts forecast MYGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYGN is 24.28 USD with a low forecast of 14.14 USD and a high forecast of 36.75 USD.

Lowest
Price Target
14.14 USD
13% Downside
Average
Price Target
24.28 USD
50% Upside
Highest
Price Target
36.75 USD
127% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MYGN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MYGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MYGN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

MYGN News

Other Videos

Profile

Myriad Genetics Inc Logo
Myriad Genetics Inc

Country

United States of America

Industry

Biotechnology

Market Cap

1.5B USD

Dividend Yield

0%

Description

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company is headquartered in Salt Lake City, Utah and currently employs 2,400 full-time employees. The firm primarily provides testing and collaborative development of testing that is designed to assess an individual’s risk for developing the disease later in life, identify a patient’s likelihood of responding to drug therapy and guide a patient’s dosing to ensure optimal treatment, or assess a patient’s risk of disease progression, and includes corporate services, such as finance, human resources, legal and information technology. The firm discovers and commercializes genetic tests. The firm's products include MyRisk, BRACAnalysis, BRACAnalysis CDx, MyChoice CDx, Prolaris, EndoPredict, Foresight and Prequel, GeneSight, Vectra. The Company’s wholly owned subsidiaries include Myriad Genetic Laboratories, Inc., Assurex Health, Inc., Myriad Women’s Health, Inc, Myriad Genetics Espana SL, Myriad Genetics S.r.l., Myriad Genetics B.V. and Myriad Genetics GK.

Contact

UTAH
Salt Lake City
320 S Wakara Way
+18015843600.0
www.myriad.com

IPO

1995-10-06

Employees

2 400

Officers

CEO, President & Director
Mr. Paul J. Diaz
Chief Operating Officer
Mr. Samraat S. Raha
Chief Scientific Officer
Dr. Dale Muzzey Ph.D.
Chief Commercial Officer
Mr. Mark S. Verratti
Chief Financial Officer
Mr. Scott J. Leffler
Principal Accounting Officer
Ms. Natalie Munk
Show More
Chief Technology Officer
Dr. Kevin Richard Haas Ph.D.
Senior Vice President of Investor Relations
Mr. Matthew Scalo
Chief Legal Officer
Ms. Jennifer L. Fox
Senior VP & Chief Marketing Officer
Mr. Glenn Farrell
Show Less

See Also

Discover More
What is the Intrinsic Value of one MYGN stock?

The intrinsic value of one MYGN stock under the Base Case scenario is 22.15 USD.

Is MYGN stock undervalued or overvalued?

Compared to the current market price of 16.17 USD, Myriad Genetics Inc is Undervalued by 27%.

Back to Top